4.8 Article

A naturally occurring variant of the human prion protein completely prevents prion disease

期刊

NATURE
卷 522, 期 7557, 页码 478-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature14510

关键词

-

资金

  1. UK Medical Research Council
  2. Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme
  3. MRC [MC_U123160655, MC_U123192748, MC_U123160653] Funding Source: UKRI
  4. Medical Research Council [MC_U123160653, MC_U123192748, MC_U123160655] Funding Source: researchfish

向作者/读者索取更多资源

Mammalian prions, transmissible agents causing lethal neuro-degenerative diseases, are composed of assemblies of misfolded cellular prion protein (PrP)(1). A novel PrP variant, G127V, was under positive evolutionary selection during the epidemic of kuru-an acquired prion disease epidemic of the Fore population in Papua New Guinea-and appeared to provide strong protection against disease in the heterozygous state(2). Here we have investigated the protective role of this variant and its interaction with the common, worldwide M129V PrP polymorphism. V127 was seen exclusively on a M129 PRNP allele. We demonstrate that transgenic mice expressing both variant and wild-type human PrP are completely resistant to both kuru and classical Creutzfeldt-Jakob disease (CJD) prions (which are closely similar) but can be infected with variant CJD prions, a human prion strain resulting from exposure to bovine spongiform encephalopathy prions to which the Fore were not exposed. Notably, mice expressing only PrP V127 were completely resistant to all prion strains, demonstrating a different molecular mechanism to M129V, which provides its relative protection against classical CJD and kuru in the heterozygous state. Indeed, this single amino acid substitution (G -> V) at a residue invariant in vertebrate evolution is as protective as deletion of the protein. Further study in transgenic mice expressing different ratios of variant and wild-type PrP indicates that not only is PrP V127 completely refractory to prion conversion but acts as a potent dose-dependent inhibitor of wild-type prion propagation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据